The clinical trials below are available in the specialty you selected. Choose a different specialty.

Alzheimer's Disease Prevention Registry
If you are over age 55 and interested in participating in future research opportunities, please join the Alzheimer's Disease Prevention Registry. (REF# 12552)

Aspirin Research Study
Participants are needed for a research study examining the effects of four-week aspirin use on platelets and whole blood. (REF# 19175)

Eating Disorder Treatment Study: Research Study on Adolescent Eating Disorders, Helping Parents Help Their Children
Children and adolescents who are picky with eating, weight conscience, throw up after meals, and have had recent weight loss may qualify for a new study treatment. (REF# 7767)

The AAKOMA Project
A study of how African American adolescents and families identify and deal with emotional and behavioral concerns. (REF# 9065)

Influenza Research Study on Young Adults
Participants age 21-40 needed for Influenza Research Study to develop a vaccine that provides protection to older adults against influenza A virus. (REF# 8342)

Harmony Type 2 Diabetes Study
Patients with type 2 diabetes may be eligible to participate in this clinical research study. (REF# 16923)

Is your planned chemotherapy likely to cause hair loss?
Participants needed for a research study evaluating methods to assess chemotherapy-induced hair loss. (REF# 4438)

Effects of One-Time Pregnenolone, DHEA, or Placebo Administration on Withdrawal Symptoms, Mood, Craving, and Cigarette Evaluation Ratings in Male Smokers
The purpose of this study is to investigate DHEA, DHEAS, allopregnanolone, pregnenolone, other steroids, other small molecules, and proteins in the blood of male smokers to find out the possible relationship of these molecules to levels of nicotine dependence and negative emotions. (REF# 8225)

Do You or Your Loved One Have Memory Problems?
A phase 3 multicenter, randomized, placebo-controlled, 12-month safety and efficacy study evaluating dimebon in patients with mild-to-moderate Alzheimer’s disease on donepezil. (REF# 15701)

Double-Blind Placebo-Controlled Preliminary Study of Efficacy, Safety, and Tolerability of ST101 in Treatment of Alzheimer’s Disease in Subjects Concurrently Receiving Donepezil (Aricept®)
You or your loved one may be eligible for participation in an investigational drug study
for Alzheimer’s disease if you qualify. (REF# 15288)

Page 1 2 of 2